Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive form of blood cancer that primarily affects older adults. It is characterized by the proliferation of precursors of ...

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Forecast DelveInsight’s Blastic Plasmacytoid Dendritic Cell Neoplasm Market report offers an in-depth understanding of the epidemiology and market t ...

medsci.uu.se Objectives Patients with systemic lupus erythematosus (SLE) have an ongoing interferon-α (IFN-α) production by plasmacytoid dendritic cells (pDCs). We investigated whether T cells can ...

10 CD123 is the α chain of the interleukin-3 receptor, and is a sensitive and specific marker of plasmacytoid dendritic cells (pDC). However, although CD123 is currently the most important marker in ...

Type I interferon signature found in SSc propelled us to study plasmacytoid dendritic cells (pDCs) in this disease. We aimed to identify candidate pathways underlying pDC aberrancies in SSc and to ...

However which bacteria confer benefit and mechanisms of action remain poorly defined. Dendritic cells, which are pivotal in early bacterial recognition, tolerance induction, and shaping of T cell ...

The molecular players and pathways involved in internalization and recycling have previously been studied in model cell lines such as HeLa. However, dendritic cells (DCs), which rely on a specialized ...

The animal ethics committee of VIB Inflammation Research Center and University Hospital Ghent approved all experiments. Bone marrow cells were freshly isolated from femur and tibia by crushing in RPMI ...

1Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 2Department of Surgery, Keio ...

The revised work remains incomplete due to remaining concerns about experimental methodology, cell health, and lack of dendritic Na-spikes which have been recorded in previous works. Non-linear ...

1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.